Gómez L, Sotoca J, Jiménez J, González-Alonso del Hoyo R, Mareque M, Oyagüez I
Análisis de costes de nusinersen a dosis altas en el manejo de la atrofia muscular espinal en España
XIV Jornadas Nacionales Gestión Sanitaria en la Nueva Era: Estrategia, Innovación y Tecnología. Sociedad Española de Directivos de la Salud (SEDISA). Toledo. 15-17 abr 2026
Rodríguez-Gil MA, García Boyero R, de Miguel Llorente D, Olave Rubio MT, Domínguez-Hernández R, Pardo C, Martín-Escudero V, Redondo Izal AM 7
The economic benefit for patients and caregivers of expanding CAR-T centres in Spain
EBMT 52nd Annual Meeting. Madrid. 22-25 mar 2026
Fernández A, González Astorga B, Rodríguez N, Safont MJ, Castro Albarran P, Mareque M, Oyagüez I
A cost analysis of adverse event management of systemic therapies for metastatic colorectal cancer on patients with at least two previous lines of treatment in Spain
Clinicoecon Outcomes Res. 2026;18:586388. doi: 10.2147/CEOR.S586388
Budget impact analysis of robot-assisted versus conventional spine surgery in Spain
Proyecto CUDERMA: Consenso Delphi de los indicadores de calidad para la certificación de las unidades de dermatología de atención en hidradenitis supurativa
Journal of Robotic Surgery (in press)
MÁS INFORMACIÓN
Ampuero J, Morillas R, Cantero H, de Pedro S, Mareque M
Economic burden of Primary Biliary Cholangitis (PBC) in Spain
Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Glasgow (Escocia). 9-12 nov 2025
Ampudia-Blasco FJ, Oyagüez I, Mezquita-Raya P, Hernández AM, Cebrián-Cuenca A, Carretero J, Bellido V, Gómez-Peralta F
Cost Analysis of FreeStyle Libre® Systems in Patients with Type 2 Diabetes Receiving Basal Insulin and Poor Glycemic Control (HbA1c > 8%): A Societal Perspective in Spain
85th Scientific Sessions – American Diabetes Association (ADA). Chicago. 20-30 jun 2025
Buti M, Cabezas J, Domínguez-Hernández R, Cantero H, Casado MA
Socioeconomic Impact of Chronic Delta Hepatitis in Spain: Indirect Costs of Work Absenteeism, Presenteeism, and Premature Mortality
PLoS One. 2025;20(6):e0324834. doi: 10.1371/journal.pone.0324834
Gómez-Peralta F, De la Cuadra-Grande A, Mezquita-Raya P, Hernández Martínez AM, Cebrián-Cuenca AM, Carretero-Gómez J, Bellido-Castañeda V, Ampudia-Blasco FJ
Cost-Analysis of FreeStyle Libre Devices from the National Health System Perspective in Patients with T2D on Basal Insulin Treatment and Poor Glycemic Control in Spain
18th International Conference on Advanced Technologies & treatments for Diabetes (ATTD). Amsterdam. 19-22 mar 2024
Subiran R, Becerra M, Castro-Albarrán P, Oyagüez I